- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04086069
Sit-to-stand Trainer in Patients After Lower Limb Amputation (STSTrainer)
February 12, 2021 updated by: University Rehabilitation Institute, Republic of Slovenia
Effect of Sit-to-stand Trainer in Patients With Unilateral Lower Limb Amputation on the Ability of Independent Standing up
The study will include rehabilitation inpatients after unilateral lower limb amputation who are candidates for walking with a prosthesis.
Those in the experimental group will receive training using a sit-to-stand trainer device in addition to standard training of standing-up with the help of a physiotherapist.
Those in the control group will only receive the standard training.
The effects of the rehabilitation programme will be assessed using the 30-Second Chair Stand Test before the start of the training and after 10 days of training.
For the first five patients from each group who will be able to stand up with the use of hands, detailed kinesiological analysis of standing-up pattern will be performed.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- University Rehabilitation Institute, Republic of Slovenia
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- unilateral lower-limb amputation
- candidate for walking with a prosthesis
- Montreal Cognitive Assessment (MoCA) test score 26 or more
Exclusion Criteria:
- associated neurological or orthopaedic disease
- amputation caused by cancer or injury
- BMI below 18.5 or above 30
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Standard Training+Sit-to-stand trainer
Training using a sit-to-stand trainer device in addition to standard training of standing-up with the help of a physiotherapist
|
The sit-to-stand trainer device is an exoskeleton that enables standing-up movement resembling the movement of a healthy person.
It consists of three sub-systems: a foldable chair, a lever for body orientation and a triggering mechanism.
It includes a support for feet with adjustable height.
The device offers partial support to the patient while standing up.
The patient will exercise with the device for 10 sessions (one per day), standing up for up to 30 times per session.
|
|
NO_INTERVENTION: Standard Training
Standard training of standing-up with the help of a physiotherapist
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in 30-Second Chair Stand Test
Time Frame: Change from day 0 to day 10
|
The test measures the number of times the participant is able to stand and return to a seated position in a chair in 30 seconds.
|
Change from day 0 to day 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standing-up pattern
Time Frame: On day 10 after the last training session
|
Detailed qualitative kinesiological analysis Will be performed to determine the standing-up pattern.
|
On day 10 after the last training session
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Berg Balance Scale
Time Frame: On day 10 after the last training session
|
The scale measures functional balance.
The participants are asked to perform 14 tasks frequently used in daily life activities.
The highest possible score is 56 points.
A higher score indicates better balance.
|
On day 10 after the last training session
|
|
6-Minute Walk Test
Time Frame: On day 10 after the last training session
|
The test measures the distance an individual is able to walk over a total of six minutes on a hard, flat surface.
Longer distance indicates better functional capacity.
|
On day 10 after the last training session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 6, 2019
Primary Completion (ACTUAL)
August 30, 2020
Study Completion (ACTUAL)
August 30, 2020
Study Registration Dates
First Submitted
September 5, 2019
First Submitted That Met QC Criteria
September 9, 2019
First Posted (ACTUAL)
September 11, 2019
Study Record Updates
Last Update Posted (ACTUAL)
February 16, 2021
Last Update Submitted That Met QC Criteria
February 12, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- URIS201903
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lower Limb Amputation
-
University of Nevada, Las VegasUnited States Department of Defense; National Institutes of Health (NIH); University... and other collaboratorsRecruitingLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Amputation | Lower Limb Amputation Knee | Lower Limb Amputation at Ankle (Injury) | Lower Limb Amputation at Hip (Injury)United States
-
Otto Bock Healthcare Products GmbHHanger Clinic: Prosthetics & OrthoticsActive, not recruitingLower Limb Amputation Above Knee (Injury) | Lower Limb Amputation Knee | Congenital Amputation of Lower LimbUnited States
-
Campus Bio-Medico UniversityFondazione Don Carlo Gnocchi OnlusRecruitingLower Limb Amputation Below Knee | Lower Limb Amputation Above KneeItaly
-
Otto Bock France SNCRecruitingLower Limb Amputation Below Knee | Lower Limb Amputation Above KneeFrance
-
Sint MaartenskliniekCompletedLower Limb Amputation Above Knee (Injury) | Lower Limb Amputation KneeNetherlands
-
Tezel Yıldırım ŞahanCompletedValidity and Reliability of The 3-Meter Backward Walk Test in Individuals With Lower Limb AmputationLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation KneeTurkey
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR)RecruitingLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Amputation | Behavior | Lower Limb Amputation KneeCanada
-
Uskudar UniversityActive, not recruitingAmputation | Lower Limb AmputationTurkey (Türkiye)
-
Sint MaartenskliniekCompletedAmputation | Lower Limb AmputationNetherlands
-
Otto Bock Healthcare Products GmbHCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury) | Lower Limb Amputation KneeUnited States
Clinical Trials on Sit-to-stand trainer
-
Hamilton Health Sciences CorporationOntario Ministry of Health and Long Term CareUnknownCerebrovascular AccidentCanada
-
Lisa GriffinRecruitingHealthy Aging | Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy Type 2 | Diabetic Peripheral Neuropathy Type 2 - UncontrolledUnited States
-
Riphah International UniversityCompletedCerebral PalsyPakistan
-
University of ZurichCompletedHealthy IndividualsSwitzerland
-
University Hospital, RouenTerminated
-
National Taiwan University HospitalCompletedUnable to Sit-to-stand | ICU SurvivorTaiwan
-
University of AlbertaCanadian Institutes of Health Research (CIHR); CapitalCare Continuing Care; E... and other collaboratorsCompleted
-
Cliniques universitaires Saint-Luc- Université...Completed
-
University Hospital, GrenobleCompletedIdiopathic Pulmonary FibrosisFrance